Daniel Javitt, M.D., Ph.D.
Dr. Javitt is Professor of Psychiatry and Neuroscience at Columbia University College of Physicians and Surgeons where he directs the Division of Experimental Therapeutics. In addition, he serves as Director of Schizophrenia Research at Nathan Kline Institute for Psychiatric Research, a New York State Office of Mental Health-supported research facility.
Dr. Javitt received his BA, magna cum laude from Princeton University in 1979 and his MD from Albert Einstein College of Medicine in 1983. He completed his residency in Psychiatry in 1987, and earned a PhD in Neuroscience from Einstein in 1990. He has published over 250 articles on issues related to normal brain function, NMDA receptors and schizophrenia, with over 28,000 citations to date. In addition, his work has been featured in Scientific American and other popular science venues.
He has received numerous prestigious research awards, including the Penwalt Resident Research Award from the American Psychiatric Association in 1987; The Kempf Fund Award for Research Development from the American Psychiatric Association in 1992 the A.E. Bennett Basic Science Award from the Society for Biological Psychiatry in 1998; the Joel Elkes Research Award from the American College of Neuropsychopharmacology in 2002; a MERIT award from the National Institutes of Mental Health in 2003; the Alexander Gralnick Award from the Child Welfare League of America in 2007; the Stanley Dean Award for Schizophrenia Research from the American College of Psychiatrists in 2012, and the Research Award from the American Psychiatric Association in 2013.